Crossmark

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Crossref DOI link: https://doi.org/10.1186/s40425-018-0353-7

Published Online: 2018-05-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Läubli, Heinz https://orcid.org/0000-0002-8910-5620
Balmelli, Catharina

Kaufmann, Lukas

Stanczak, Michal

Syedbasha, Mohammedyaseen

Vogt, Dominik

Hertig, Astrid

Müller, Beat

Gautschi, Oliver

Stenner, Frank

Zippelius, Alfred

Egli, Adrian

Rothschild, Sacha I.
Funding

Funding for this research was provided by:

Schoenmakers Foundation (-)

Goldschmidt-Jacobson Foundation (-)

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PZ00P3_154709 / 1, 320030_162575)
License Information

Text and Data Mining valid from 2018-05-22
More Information

Article History

Received: 27 February 2018

Accepted: 9 May 2018

First Online: 22 May 2018

Ethics approval and consent to participate

: This observational study was performed in accordance with institutional review board approval by the local ethical committee (ethical committee of northwestern and central part of Switzerland, EKNZ, approval number EK321/10) and informed consent was obtained from each participant.

: All co-investigators have substantially contributed to this work and gave their consent to the current manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.